U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX24068120: GSM8171497: Kdm6a +/+ line 4, D14, exp2; Mus musculus; RNA-Seq
2 ILLUMINA (Illumina NovaSeq 6000) runs: 49.4M spots, 9.9G bases, 3Gb downloads

External Id: GSM8171497_r1
Submitted by: Johns Hopkins University School of Medicine
Study: Growth retardation in a mouse model of Kabuki syndrome 2 bears mechanistic similarities to Kabuki syndrome 1.
show Abstracthide Abstract
Growth deficiency is a characteristic feature of both Kabuki syndrome 1 (KS1) and Kabuki syndrome 2 (KS2), Mendelian disorders of the epigenetic machinery with similar phenotypes but distinct genetic etiologies. We previously described skeletal growth deficiency in a mouse model of KS1 and further established that a Kmt2d -/- chondrocyte model of KS1 exhibits precocious differentiation. Here we characterized growth deficiency in a mouse model of KS2, Kdm6a tm1d/+. We show that Kdm6a tm1d/+ mice have decreased femur and tibia length compared to controls and exhibit abnormalities in cortical and trabecular bone structure. Kdm6a tm1d/+ growth plates are also shorter, due to decreases in hypertrophic chondrocyte size and hypertrophic zone height. Given these disturbances in the growth plate, we generated Kdm6a -/- chondrogenic cell lines. Similar to our prior in vitro model of KS1, we found that Kdm6a -/- cells undergo premature, enhanced differentiation towards chondrocytes compared to Kdm6a +/+ controls. RNA-seq showed that Kdm6a -/- cells have a distinct transcriptomic profile that indicates dysregulation of cartilage development. Finally, we performed RNA-seq simultaneously on Kmt2d -/-, Kdm6a -/-, and control lines at Days 7 and 14 of differentiation. This revealed surprising resemblance in gene expression between Kmt2d -/- and Kdm6a -/- at both time points and indicates that the similarity in phenotype between KS1 and KS2 also exists at the transcriptional level. Overall design: We generated Kdm6a -/- and Kdm6a +/+ cell lines from the murine teratocarcinoma parental cell line ATDC5 using CRISPR-Cas9. For the first experiment, we differentiated Kdm6a -/- and Kdm6a +/+ cells towards chondrocytes for 14 days. We then harvested RNA and performed library prep for RNA-seq. For the second experiment, we performed chondrogenic differentiation on Kdm6a -/- and Kdm6a +/+ cells as well as Kmt2d -/- and Kmt2d +/+ cell lines, previously generated from the same parental ATDC5 cell line. We collected samples for RNA-seq at both Day 7 and Day 14 of differentiation for all cell lines.
Sample: Kdm6a +/+ line 4, D14, exp2
SAMN40622322 • SRS20858836 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM8171497
Instrument: Illumina NovaSeq 6000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Cells were homogenized with TRIzol reagent, followed by phenol-chloroform separation. Total RNA was purified from the aqueous phase using the Zymo RNA Clean and Concentrator-5 kit with DNase I treatment. Library preparation was performed with the NEBNext Ultra II RNA Library Prep kit in conjunction with NEBNext Poly(A) mRNA Magnetic Isolation Module.
Runs: 2 runs, 49.4M spots, 9.9G bases, 3Gb
Run# of Spots# of BasesSizePublished
SRR2846499724,685,3344.9G1.5Gb2024-03-30
SRR2846499824,677,3094.9G1.5Gb2024-03-30

ID:
32375560

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...